首页 > 最新文献

International journal of Ayurveda research最新文献

英文 中文
A survey of the labeling information provided for ayurvedic drugs marketed in India. 对在印度销售的阿育吠陀药物提供的标签信息的调查。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76785
Supriya Bhalerao, Renuka Munshi, Prajakta Tilve, Dipti Kumbhar

Background: Ayurvedic drugs fall under the purview of the Drugs and Cosmetics Act, 1940 and labels on Ayurvedic drug containers need to comply with the requirements specified in this Act (Part XVII, 161). The present survey was conducted to evaluate whether Ayurvedic drug labels were in compliance with the Drugs and Cosmetics Act, 1940 with respect to their contents.

Materials and methods: Ayurvedic drugs container labels at three Ayurvedic pharmacies were selected based on the convenience sampling method. Their contents were checked against a set of quality criteria given in the Act. The results are expressed as percentages.

Results: Basic manufacturing details were present on all the 190 labels reviewed (101 classical and 89 proprietary formulations). References from authoritative books as specified in the 1st Schedule of the Act were mentioned on 90% of labels of the 101 classical formulations reviewed. Fifty-five percent (n = 56) labels of classical drugs and 79 (88%) labels of proprietary drugs provided an ingredient list. Although 20 (20%) of classical formulations and 13 (15%) of proprietary formulations labels mentioned the Cautions/Warnings, only one language (either English or Hindi) was used.

Conclusion: Ayurvedic drug container labels were not compliant with most of the requirements specified in the Act.

背景:阿育吠陀药物属于1940年《药品和化妆品法》的管辖范围,阿育吠陀药物容器上的标签需要符合该法案规定的要求(第XVII部分,161)。本调查的目的是评估阿育吠陀药物标签的内容是否符合1940年《药品和化妆品法》的规定。材料与方法:采用方便抽样法,选取三家阿育吠陀药店的阿育吠陀药品容器标签。它们的内容是根据该法规定的一套质量标准进行检查的。结果以百分比表示。结果:审查的所有190个标签(101个经典配方和89个专有配方)上都有基本的生产细节。在审查的101个经典配方中,90%的标签上提到了该法案附表1中指定的权威书籍的参考资料。55% (n = 56)的经典药和79(88%)的中成药标签提供了成分表。尽管20个(20%)经典配方和13个(15%)专有配方的标签提到了注意事项/警告,但只使用了一种语言(英语或印地语)。结论:阿育吠陀药品容器标签不符合法案规定的大部分要求。
{"title":"A survey of the labeling information provided for ayurvedic drugs marketed in India.","authors":"Supriya Bhalerao,&nbsp;Renuka Munshi,&nbsp;Prajakta Tilve,&nbsp;Dipti Kumbhar","doi":"10.4103/0974-7788.76785","DOIUrl":"https://doi.org/10.4103/0974-7788.76785","url":null,"abstract":"<p><strong>Background: </strong>Ayurvedic drugs fall under the purview of the Drugs and Cosmetics Act, 1940 and labels on Ayurvedic drug containers need to comply with the requirements specified in this Act (Part XVII, 161). The present survey was conducted to evaluate whether Ayurvedic drug labels were in compliance with the Drugs and Cosmetics Act, 1940 with respect to their contents.</p><p><strong>Materials and methods: </strong>Ayurvedic drugs container labels at three Ayurvedic pharmacies were selected based on the convenience sampling method. Their contents were checked against a set of quality criteria given in the Act. The results are expressed as percentages.</p><p><strong>Results: </strong>Basic manufacturing details were present on all the 190 labels reviewed (101 classical and 89 proprietary formulations). References from authoritative books as specified in the 1st Schedule of the Act were mentioned on 90% of labels of the 101 classical formulations reviewed. Fifty-five percent (n = 56) labels of classical drugs and 79 (88%) labels of proprietary drugs provided an ingredient list. Although 20 (20%) of classical formulations and 13 (15%) of proprietary formulations labels mentioned the Cautions/Warnings, only one language (either English or Hindi) was used.</p><p><strong>Conclusion: </strong>Ayurvedic drug container labels were not compliant with most of the requirements specified in the Act.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"220-2"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76785","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29784563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
About gold in human semen. 关于人类精液中的黄金。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76798
Kp Skandhan, B Sumangala, P Sahab Khan, S Amith, Kps Avni
{"title":"About gold in human semen.","authors":"Kp Skandhan,&nbsp;B Sumangala,&nbsp;P Sahab Khan,&nbsp;S Amith,&nbsp;Kps Avni","doi":"10.4103/0974-7788.76798","DOIUrl":"https://doi.org/10.4103/0974-7788.76798","url":null,"abstract":"","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"282-3"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76798","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29783390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Effect of Tectona grandis Linn. seeds on hair growth activity of albino mice. Tectona grandis Linn.种子对白化小鼠毛发生长活性的影响
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76783
Deepali Jaybhaye, Sushikumar Varma, Nitin Gagne, Vijay Bonde, Amol Gite, Deepak Bhosle

The seeds of Tectona grandis Linn. are traditionally acclaimed as hair tonic in the Indian system of medicine. Studies were therefore undertaken in order to evaluate petroleum ether extract of T. grandis seeds for its effect on hair growth in albino mice. The 5% and 10% extracts incorporated into simple ointment base were applied topically on shaved denuded skin of albino mice. The time required for initiation of hair growth as well as completion of hair growth cycle was recorded. Minoxidil 2% solution was applied topically and served as positive control. The result of treatment with minoxidil 2% is 49% hair in anagenic phase. Hair growth initiation time was significantly reduced to half on treatment with the extracts compared to control animals. The treatment was successful in bringing a greater number of hair follicles (64% and 51%) in anagenic phase than standard minoxidil (49%). The results of treatment with 5% and 10% petroleum ether extracts were comparable to the positive control minoxidil.

在印度医学体系中,Tectona grandis Linn.的种子历来被认为是头发的滋补品。因此,研究人员开展了一项研究,以评估 Tectona grandis 种子的石油醚提取物对白化小鼠毛发生长的影响。将 5% 和 10% 的提取物加入简单的软膏基质中,局部涂抹在白化小鼠剃光的脱毛皮肤上。记录毛发开始生长和完成生长周期所需的时间。米诺地尔 2% 溶液作为阳性对照。米诺地尔 2% 的治疗结果是,49% 的毛发处于生长期。与对照组相比,使用萃取物治疗后,毛发的生长启动时间明显缩短了一半。与标准米诺地尔(49%)相比,该疗法成功地使更多的毛囊(64% 和 51%)进入生长期。5%和10%石油醚提取物的治疗效果与阳性对照米诺地尔相当。
{"title":"Effect of Tectona grandis Linn. seeds on hair growth activity of albino mice.","authors":"Deepali Jaybhaye, Sushikumar Varma, Nitin Gagne, Vijay Bonde, Amol Gite, Deepak Bhosle","doi":"10.4103/0974-7788.76783","DOIUrl":"10.4103/0974-7788.76783","url":null,"abstract":"<p><p>The seeds of Tectona grandis Linn. are traditionally acclaimed as hair tonic in the Indian system of medicine. Studies were therefore undertaken in order to evaluate petroleum ether extract of T. grandis seeds for its effect on hair growth in albino mice. The 5% and 10% extracts incorporated into simple ointment base were applied topically on shaved denuded skin of albino mice. The time required for initiation of hair growth as well as completion of hair growth cycle was recorded. Minoxidil 2% solution was applied topically and served as positive control. The result of treatment with minoxidil 2% is 49% hair in anagenic phase. Hair growth initiation time was significantly reduced to half on treatment with the extracts compared to control animals. The treatment was successful in bringing a greater number of hair follicles (64% and 51%) in anagenic phase than standard minoxidil (49%). The results of treatment with 5% and 10% petroleum ether extracts were comparable to the positive control minoxidil.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"211-5"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/e6/IJAR-1-211.PMC3059442.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29784561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacognostic study of Chlorophytum tuberosum Baker. 吊兰的生药学研究。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76788
V N Patil, S S Deokule

Chlorophytum tuberosum Baker belongs to family Liliaceae and is being used in the indigenous systems of medicine as a galactogogue and aphrodisiac. It is being sold in the market under the common name safed musali. The white tuberous roots of this plant are the medicinally useful parts. The tuberous roots of other species of Chlorophytum, Asparagus, Bombax and Orchids are also sometimes called safed musali leading to confusion. In order to ensure correct botanical standardization to remove the controversy, a detailed pharmacognostic study on tuberous roots of Chlorophytum has been carried out in this study .

吊兰(吊兰)是百合科植物,作为催乳剂和催情剂在本土医学系统中被广泛使用。它在市场上以通用名称safed musali出售。这种植物的白色块茎根是药用部位。其他种类的吊兰、芦笋、梧桐和兰花的块茎根有时也被称为safed musali,导致混淆。为了保证正确的植物学标准化,消除争议,本研究对吊兰块根进行了详细的生药学研究。
{"title":"Pharmacognostic study of Chlorophytum tuberosum Baker.","authors":"V N Patil,&nbsp;S S Deokule","doi":"10.4103/0974-7788.76788","DOIUrl":"https://doi.org/10.4103/0974-7788.76788","url":null,"abstract":"<p><p>Chlorophytum tuberosum Baker belongs to family Liliaceae and is being used in the indigenous systems of medicine as a galactogogue and aphrodisiac. It is being sold in the market under the common name safed musali. The white tuberous roots of this plant are the medicinally useful parts. The tuberous roots of other species of Chlorophytum, Asparagus, Bombax and Orchids are also sometimes called safed musali leading to confusion. In order to ensure correct botanical standardization to remove the controversy, a detailed pharmacognostic study on tuberous roots of Chlorophytum has been carried out in this study .</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"237-42"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76788","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29783383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Sphaeranthus indicus Linn.: A phytopharmacological review. 印度Sphaeranthus indicus Linn.:植物药理学综述。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76790
Varsha J Galani, B G Patel, D G Rana

Sphaeranthus indicus Linn. (Asteraceae) is widely used in Ayurvedic system of medicine to treat vitiated conditions of epilepsy, mental illness, hemicrania, jaundice, hepatopathy, diabetes, leprosy, fever, pectoralgia, cough, gastropathy, hernia, hemorrhoids, helminthiasis, dyspepsia and skin diseases. There are reports providing scientific evidences for hypotensive, anxiolytic, neuroleptic, hypolipidemic, immunomodulatory, antioxidant, anti-inflammatory, bronchodialatory, antihyperglycemic and hepatoprotective activities of this plant. A wide range of phytochemical constituents have been isolated from this plant including sesquiterpene lactones, eudesmenolides, flavanoids and essential oil. A comprehensive account of the morphology, phytochemical constituents, ethnobotanical uses and pharmacological activities reported are included in this review for exploring the immense medicinal potential of this plant.

在阿育吠陀医学体系中,Sphaeranthus indicus Linn.(菊科)被广泛用于治疗癫痫、精神病、颅内出血、黄疸、肝病、糖尿病、麻风病、发热、胸痛、咳嗽、胃病、疝气、痔疮、蠕虫病、消化不良和皮肤病等疾病。一些报告提供了科学证据,证明这种植物具有降血压、抗焦虑、神经抑制、降血脂、免疫调节、抗氧化、抗炎、支气管扩张、降血糖和保护肝脏的活性。从这种植物中分离出了多种植物化学成分,包括倍半萜内酯、桉叶内酯、黄酮类化合物和精油。本综述全面介绍了这种植物的形态、植物化学成分、民族植物学用途和药理活性,以探索其巨大的药用潜力。
{"title":"Sphaeranthus indicus Linn.: A phytopharmacological review.","authors":"Varsha J Galani, B G Patel, D G Rana","doi":"10.4103/0974-7788.76790","DOIUrl":"10.4103/0974-7788.76790","url":null,"abstract":"<p><p>Sphaeranthus indicus Linn. (Asteraceae) is widely used in Ayurvedic system of medicine to treat vitiated conditions of epilepsy, mental illness, hemicrania, jaundice, hepatopathy, diabetes, leprosy, fever, pectoralgia, cough, gastropathy, hernia, hemorrhoids, helminthiasis, dyspepsia and skin diseases. There are reports providing scientific evidences for hypotensive, anxiolytic, neuroleptic, hypolipidemic, immunomodulatory, antioxidant, anti-inflammatory, bronchodialatory, antihyperglycemic and hepatoprotective activities of this plant. A wide range of phytochemical constituents have been isolated from this plant including sesquiterpene lactones, eudesmenolides, flavanoids and essential oil. A comprehensive account of the morphology, phytochemical constituents, ethnobotanical uses and pharmacological activities reported are included in this review for exploring the immense medicinal potential of this plant.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"247-53"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/b6/IJAR-1-247.PMC3059449.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29783385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacognostical and physicochemical evaluation of Agasti leaf. 阿加藤叶的生药学和理化评价。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76787
Pramod Yadav, C R Harisha, P K Prajapati

Sesbania grandiflora (L.) Pers., commonly known as Agasti, is widely used in Ayurveda for the treatment of diseases and for processing of various formulations in Rasashastra. It is used for its astringent, antihistaminic, anxiolytic, anticonvulsive and febrifugal activities. Moreover, because of its edible nature, the leaves and pods are used as flavoring items in the cuisine of South India. A detailed investigation of fresh and powder of leaves of Agasti was carried out. The diagnostic characters of this plant include stomatal characters, presence of resins, oil globules, appressed epidermal hair and mucilage cells. Physicochemical studies revealed loss on drying (0.6%), total ash (10.75%), acid insoluble ash (0.045%), alcohol-soluble extractive (21.7%), and water-soluble extractive (30.72%). Preliminary analysis for the presence of various functional groups revealed the presence of alkaloids, saponins, phenols and proteins. Thin layer chromatographic study of the alcoholic extract showed the presence of five, six and seven spots in short UV, long UV and after spraying developing reagent, respectively. The information generated by this particular study will provide relevant pharmacognostical and physicochemical data needed for proper identification and authentication of leaves of this particular species.

大田葵(L.)珀耳斯。通常被称为Agasti,在阿育吠陀中被广泛用于治疗疾病和在Rasashastra中加工各种配方。它具有收敛、抗组胺、抗焦虑、抗惊厥和发热的作用。此外,由于其可食用的性质,它的叶子和豆荚被用作南印度菜肴的调味品。对阿加藤鲜叶和粉叶进行了详细的研究。该植物的诊断特征包括气孔特征、树脂、油球、附着的表皮毛和粘液细胞的存在。理化研究表明,干燥损失(0.6%)、总灰分损失(10.75%)、酸不溶灰分损失(0.045%)、醇溶萃取物损失(21.7%)和水溶性萃取物损失(30.72%)。初步分析了各种官能团的存在,发现存在生物碱、皂苷、酚类和蛋白质。薄层色谱研究表明,在短紫外、长紫外和喷涂显影剂后,乙醇提取物分别存在5个、6个和7个斑点。本研究所产生的信息将为该植物叶片的正确鉴定和鉴定提供相关的生药学和理化数据。
{"title":"Pharmacognostical and physicochemical evaluation of Agasti leaf.","authors":"Pramod Yadav,&nbsp;C R Harisha,&nbsp;P K Prajapati","doi":"10.4103/0974-7788.76787","DOIUrl":"https://doi.org/10.4103/0974-7788.76787","url":null,"abstract":"<p><p>Sesbania grandiflora (L.) Pers., commonly known as Agasti, is widely used in Ayurveda for the treatment of diseases and for processing of various formulations in Rasashastra. It is used for its astringent, antihistaminic, anxiolytic, anticonvulsive and febrifugal activities. Moreover, because of its edible nature, the leaves and pods are used as flavoring items in the cuisine of South India. A detailed investigation of fresh and powder of leaves of Agasti was carried out. The diagnostic characters of this plant include stomatal characters, presence of resins, oil globules, appressed epidermal hair and mucilage cells. Physicochemical studies revealed loss on drying (0.6%), total ash (10.75%), acid insoluble ash (0.045%), alcohol-soluble extractive (21.7%), and water-soluble extractive (30.72%). Preliminary analysis for the presence of various functional groups revealed the presence of alkaloids, saponins, phenols and proteins. Thin layer chromatographic study of the alcoholic extract showed the presence of five, six and seven spots in short UV, long UV and after spraying developing reagent, respectively. The information generated by this particular study will provide relevant pharmacognostical and physicochemical data needed for proper identification and authentication of leaves of this particular species.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"231-6"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76787","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29784565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Validated HPLC-UV method for the determination of berberine in raw herb Daruharidra (Berberis aristata DC), its extract, and in commercially marketed Ayurvedic dosage forms. 验证了HPLC-UV法测定天然草药小檗(Berberis aristata DC)及其提取物和市售阿育吠陀剂型中小檗碱的含量。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76789
Anubhuti Pasrija, Rahul Singh, Chandra Kant Katiyar

A new, simple, sensitive, selective, and precise high-performance liquid chromatography (HPLC) method for analysis of berberine in crude plant material, herbal extract, and ayurvedic dosage forms was developed and validated. The stationary phase was inert sil C(18) column The mobile phase consisting of acetonitrile (HPLC Grade) and potassium dihydrogen phosphate buffer (pH 2.5) in a gradient flow was used.The column was equilibrated with the mobile phase (flow rate 1.0 ml/min); elution was monitored at 346 nm. The linear regression analysis data for the calibration plots showed good linear relationship, with r(2)= 0.9942 in the concentration range of 16380-30420 μg/ml with respect to the peak area. The method was validated for specificity, precision, recovery, and linearity according to the International Conference on Harmonization guidelines. Statistical analysis of the data showed that the method is reproducible and selective for the estimation of berberine.

建立了一种简便、灵敏、选择性和精确的高效液相色谱(HPLC)方法,用于分析植物原料、草药提取物和阿育吠陀剂型中的小檗碱。固定相为C(18)柱,流动相为乙腈(HPLC级)和磷酸二氢钾缓冲液(pH 2.5),梯度流动。用流动相(流速1.0 ml/min)平衡柱;在346 nm处监测洗脱。线性回归分析结果表明,在16380 ~ 30420 μg/ml浓度范围内,峰面积r(2)= 0.9942,线性关系良好。根据国际协调会议的指导方针,验证了该方法的特异性、精密度、回收率和线性。统计分析结果表明,该方法对小檗碱的测定具有良好的重复性和选择性。
{"title":"Validated HPLC-UV method for the determination of berberine in raw herb Daruharidra (Berberis aristata DC), its extract, and in commercially marketed Ayurvedic dosage forms.","authors":"Anubhuti Pasrija,&nbsp;Rahul Singh,&nbsp;Chandra Kant Katiyar","doi":"10.4103/0974-7788.76789","DOIUrl":"https://doi.org/10.4103/0974-7788.76789","url":null,"abstract":"<p><p>A new, simple, sensitive, selective, and precise high-performance liquid chromatography (HPLC) method for analysis of berberine in crude plant material, herbal extract, and ayurvedic dosage forms was developed and validated. The stationary phase was inert sil C(18) column The mobile phase consisting of acetonitrile (HPLC Grade) and potassium dihydrogen phosphate buffer (pH 2.5) in a gradient flow was used.The column was equilibrated with the mobile phase (flow rate 1.0 ml/min); elution was monitored at 346 nm. The linear regression analysis data for the calibration plots showed good linear relationship, with r(2)= 0.9942 in the concentration range of 16380-30420 μg/ml with respect to the peak area. The method was validated for specificity, precision, recovery, and linearity according to the International Conference on Harmonization guidelines. Statistical analysis of the data showed that the method is reproducible and selective for the estimation of berberine.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"243-6"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76789","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29783384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 32
The National Pharmacovigilance Program for Ayurveda, Siddha and Unani Drugs: Current status. 阿育吠陀、悉达和乌纳尼药物的国家药物警戒计划:现状。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76779
Ms Baghel
{"title":"The National Pharmacovigilance Program for Ayurveda, Siddha and Unani Drugs: Current status.","authors":"Ms Baghel","doi":"10.4103/0974-7788.76779","DOIUrl":"https://doi.org/10.4103/0974-7788.76779","url":null,"abstract":"","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"197-8"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76779","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29784619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Efficacy and safety of livwin (polyherbal formulation) in patients with acute viral hepatitis: A randomized double-blind placebo-controlled clinical trial. 多草药制剂livwin治疗急性病毒性肝炎的疗效和安全性:一项随机双盲安慰剂对照临床试验
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76784
Yogendra Keche, Vandana Badar, Mrunalini Hardas

Objectives: The study was planned to evaluate the efficacy and safety of Livwin (polyherbal formulation) in acute viral hepatitis.

Materials and methods: In this study, there were 29 patients in each group, receiving either Livwin (containing Ashwagandha, Arjuna, Bhumyamalaki, Daruharidra, Guduchi, Kutki and Punarnava) or placebo capsules containing lactose powder (500 mg). Both drugs were given orally two capsules two times a day for eight weeks followed by treatment free period of four weeks. Recovery of patients was assessed by noting symptomatic recovery and by measuring levels of serum bilirubin, serum aspartate aminotransferase (AST), serum alanine aminotransferase (ALT), alkaline phosphatase at baseline, 2, 4, 8 and 12 weeks.

Results: Significant earlier recovery of weakness was observed with Livwin as compared to placebo at 2, 4 and 8 weeks. Serum bilirubin and ALT was observed in normal range in significantly more number of patients with Livwin treatment as compared to placebo at 2, 4 and 8 weeks. AST was observed in normal range in significantly more number of patients with Livwin treatment as compared to placebo at 2 and 4 weeks.

Conclusions: Livwin is found effective in uncomplicated patients of acute viral hepatitis. Epigastric pain and diarrhea were reported with Livwin treatment.

目的:本研究旨在评价复方Livwin治疗急性病毒性肝炎的疗效和安全性。材料与方法:本研究中,每组29例患者服用Livwin(含Ashwagandha, Arjuna, Bhumyamalaki, Daruharidra, Guduchi, Kutki和Punarnava)或含有乳糖粉的安慰剂胶囊(500 mg)。两种药物口服两粒胶囊,每天两次,持续8周,然后是4周的免费治疗期。在基线、2周、4周、8周和12周时,通过观察症状恢复情况和测定血清胆红素、血清天冬氨酸转氨酶(AST)、血清丙氨酸转氨酶(ALT)、碱性磷酸酶水平来评估患者的恢复情况。结果:与安慰剂相比,在第2周、第4周和第8周,Livwin组的虚弱恢复明显更早。在第2、4和8周,与安慰剂相比,Livwin治疗组的患者血清胆红素和ALT在正常范围内的人数明显更多。在第2周和第4周,与安慰剂相比,Livwin治疗组的AST在正常范围内的数量明显更多。结论:利夫温治疗急性病毒性肝炎疗效确切。Livwin治疗组出现上腹痛和腹泻。
{"title":"Efficacy and safety of livwin (polyherbal formulation) in patients with acute viral hepatitis: A randomized double-blind placebo-controlled clinical trial.","authors":"Yogendra Keche,&nbsp;Vandana Badar,&nbsp;Mrunalini Hardas","doi":"10.4103/0974-7788.76784","DOIUrl":"https://doi.org/10.4103/0974-7788.76784","url":null,"abstract":"<p><strong>Objectives: </strong>The study was planned to evaluate the efficacy and safety of Livwin (polyherbal formulation) in acute viral hepatitis.</p><p><strong>Materials and methods: </strong>In this study, there were 29 patients in each group, receiving either Livwin (containing Ashwagandha, Arjuna, Bhumyamalaki, Daruharidra, Guduchi, Kutki and Punarnava) or placebo capsules containing lactose powder (500 mg). Both drugs were given orally two capsules two times a day for eight weeks followed by treatment free period of four weeks. Recovery of patients was assessed by noting symptomatic recovery and by measuring levels of serum bilirubin, serum aspartate aminotransferase (AST), serum alanine aminotransferase (ALT), alkaline phosphatase at baseline, 2, 4, 8 and 12 weeks.</p><p><strong>Results: </strong>Significant earlier recovery of weakness was observed with Livwin as compared to placebo at 2, 4 and 8 weeks. Serum bilirubin and ALT was observed in normal range in significantly more number of patients with Livwin treatment as compared to placebo at 2, 4 and 8 weeks. AST was observed in normal range in significantly more number of patients with Livwin treatment as compared to placebo at 2 and 4 weeks.</p><p><strong>Conclusions: </strong>Livwin is found effective in uncomplicated patients of acute viral hepatitis. Epigastric pain and diarrhea were reported with Livwin treatment.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"216-9"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0974-7788.76784","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29784562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
A protocol for systematic reviews of Ayurveda treatments. 阿育吠陀疗法系统性审查协议。
Pub Date : 2010-10-01 DOI: 10.4103/0974-7788.76791
Saravu R Narahari, Madhur Guruprasad Aggithaya, Kumbla R Suraj

This protocol is intended primarily for Ayurveda doctors who wish to take up systematic reviews along with an expert who has experience in doing such reviews. We have structured this protocol by incorporating the principles of patient treatment in Ayurveda, within the Cochrane framework, using Vitiligo as a model. The treatment section provides a comprehensive list of classical medicines used in the treatment of the disease. This will help in increasing the search terms. Such a list also helps to determine the needs of individualized treatment principles used in the trial and to assess the confounding factors. The search strategy includes an extensive listing of eastern data bases and hand searching. In Ayurveda, the titles of articles are not in the Population, Intervention, Control, and Outcome (PICO) pattern and sometimes the title and methodology do not tally. Therefore, a search of all types of studies is necessary to pool all the relevant publications. A data extraction form is proposed for use in assessing the quality of Ayurvedic studies. The form provides a template for performing evidence reviews of Ayurvedic interventions.

本方案主要面向希望与具有系统综述经验的专家一起进行系统综述的阿育吠陀医生。我们将阿育吠陀的患者治疗原则纳入科克伦框架,并以白癜风为范例,构建了本方案。治疗部分提供了一份用于治疗该疾病的经典药物综合清单。这将有助于增加搜索条件。该列表还有助于确定试验中使用的个体化治疗原则的需求,并评估混杂因素。检索策略包括广泛列出东方数据库和手工检索。在阿育吠陀学中,文章的标题并不是按照人群、干预、控制和结果(PICO)的模式编写的,有时标题和方法并不一致。因此,有必要对所有类型的研究进行搜索,以汇集所有相关出版物。本文提出了一份数据提取表,用于评估阿育吠陀学研究的质量。该表格提供了对阿育吠陀疗法干预措施进行证据审查的模板。
{"title":"A protocol for systematic reviews of Ayurveda treatments.","authors":"Saravu R Narahari, Madhur Guruprasad Aggithaya, Kumbla R Suraj","doi":"10.4103/0974-7788.76791","DOIUrl":"10.4103/0974-7788.76791","url":null,"abstract":"<p><p>This protocol is intended primarily for Ayurveda doctors who wish to take up systematic reviews along with an expert who has experience in doing such reviews. We have structured this protocol by incorporating the principles of patient treatment in Ayurveda, within the Cochrane framework, using Vitiligo as a model. The treatment section provides a comprehensive list of classical medicines used in the treatment of the disease. This will help in increasing the search terms. Such a list also helps to determine the needs of individualized treatment principles used in the trial and to assess the confounding factors. The search strategy includes an extensive listing of eastern data bases and hand searching. In Ayurveda, the titles of articles are not in the Population, Intervention, Control, and Outcome (PICO) pattern and sometimes the title and methodology do not tally. Therefore, a search of all types of studies is necessary to pool all the relevant publications. A data extraction form is proposed for use in assessing the quality of Ayurvedic studies. The form provides a template for performing evidence reviews of Ayurvedic interventions.</p>","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"1 4","pages":"254-67"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/94/IJAR-1-254.PMC3059450.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29783386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of Ayurveda research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1